BASIC CARBOHYDRATE COUNTING IN PREDIABETES
CARB-PRED
THE EFFECT OF BASIC CARBOHYDRATE COUNTING ON HBA1C IN PREDIABETES: A RANDOMIZED CONTROLLED TRIAL
1 other identifier
interventional
120
1 country
1
Brief Summary
Type 2 diabetes mellitus (T2DM) is a major global health problem with rapidly increasing prevalence. Prediabetes represents a high-risk state for developing T2DM and is often asymptomatic, delaying diagnosis and intervention. Early identification and effective lifestyle interventions are essential to prevent or delay the progression to diabetes. Primary care settings provide an important opportunity for screening and implementing preventive strategies. Lifestyle modification, including dietary changes and physical activity, is the cornerstone of diabetes prevention. Carbohydrate counting is a medical nutrition therapy widely used in diabetes management and has been shown to improve glycemic control. However, there is limited evidence regarding its effectiveness in individuals with prediabetes. This study aims to evaluate the effect of basic carbohydrate counting education on HbA1c levels in individuals with prediabetes in a primary care setting. This randomized controlled trial will be conducted in the Family Medicine outpatient clinic of Marmara University Hospital. Individuals aged 18 years and older with HbA1c levels between 5.7% and 6.4% will be included. Participants will be randomized into intervention and control groups in a 2:1 ratio. The control group will receive standard lifestyle recommendations, while the intervention group will receive additional structured basic carbohydrate counting education in three sessions. HbA1c levels will be measured at baseline,at third and at 6 months. Secondary outcomes include body weight, body mass index, waist circumference,lipid panel and carbohydarte counting knowledge scale The findings of this study are expected to contribute to the development of effective, scalable, and practical nutritional interventions for diabetes prevention in primary care
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
April 6, 2026
CompletedFirst Posted
Study publicly available on registry
April 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
April 13, 2026
April 1, 2026
3 months
April 6, 2026
April 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The change in HbA1c level
The change in HbA1c levels from baseline to 6 months will be assessed to evaluate the effect of carbohydrate counting-based nutrition education.
from baseline to 6 months
Study Arms (2)
Control
ACTIVE COMPARATORParticipants in the control group will receive standard care without structured carbohydrate counting-based nutrition education.
intervention
EXPERIMENTALParticipants receive structured nutrition education based on carbohydrate counting, including dietary counseling and follow-up during the study period.
Interventions
Participants in the control group will receive standard care without structured carbohydrate counting-based nutrition education.
Participants assigned to the intervention group will receive a structured nutrition education program based on carbohydrate counting principles. The program will be delivered by a physician and will cover carbohydrate identification, portion estimation, meal planning, and practical application in daily dietary habits. The aim of the intervention is to improve glycemic control by increasing nutritional knowledge and promoting behavioral changes. Outcome measures will be evaluated at baseline, 3 months, and 6 months.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years and older Able to read and write Individuals with prediabetes who are not using oral antidiabetic medications or who decline pharmacological treatment
You may not qualify if:
- Individuals with a diagnosis of diabetes mellitus Those who have previously received carbohydrate counting training or are currently applying carbohydrate counting Individuals with low daily carbohydrate intake (\<100 g/day) Presence of uncontrolled medical conditions that may affect dietary intake, as determined by the investigator Pregnant or breastfeeding women, or those planning pregnancy during the study period Participation in another clinical study Inability or unwillingness to provide informed consent or comply with study procedures Cognitive impairment or communication difficulties (hearing, understanding, or speaking)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hamide Sahinlead
Study Sites (1)
Marmara University Hospital
Istanbul, Pendik, 34000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Family Medicine Specialist
Study Record Dates
First Submitted
April 6, 2026
First Posted
April 13, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
November 1, 2026
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share